Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2020-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_a55e32f0f2d042e4a3cf4a3d067ad06c | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a John K. Chan |e author |
| 700 | 1 | 0 | |a David S. Lakomy |e author |
| 700 | 1 | 0 | |a Yassmina McDonald |e author |
| 700 | 1 | 0 | |a Daniel S Kapp |e author |
| 245 | 0 | 0 | |a Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer |
| 260 | |b Elsevier, |c 2020-08-01T00:00:00Z. | ||
| 500 | |a 2352-5789 | ||
| 500 | |a 10.1016/j.gore.2020.100581 | ||
| 546 | |a EN | ||
| 690 | |a Gynecology and obstetrics | ||
| 690 | |a RG1-991 | ||
| 690 | |a Neoplasms. Tumors. Oncology. Including cancer and carcinogens | ||
| 690 | |a RC254-282 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Gynecologic Oncology Reports, Vol 33, Iss , Pp 100581- (2020) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2352578920300473 | |
| 787 | 0 | |n https://doaj.org/toc/2352-5789 | |
| 856 | 4 | 1 | |u https://doaj.org/article/a55e32f0f2d042e4a3cf4a3d067ad06c |z Connect to this object online. |